2.1. Study Design
This was an open-label, randomized controlled pilot study. The study protocol was approved by the Weill Cornell Institutional Review Board (IRB # 1807019463) and registered on ClinicalTrials.gov (NCT# NCT03896360). Enrolled participants gave written informed consent.